Arbutus Biopharma
ABUS
ABUS
24 hedge funds and large institutions have $39.5M invested in Arbutus Biopharma in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$16.1M | |
| 2 | +$4.14M | |
| 3 | +$3.98M | |
| 4 |
PC
PointState Capital
New York
|
+$2.77M |
| 5 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$1.68M |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$626K | |
| 3 | -$393K | |
| 4 |
LOM
Loeb Offshore Management
New York
|
-$70K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$63K |